Literature DB >> 23449595

When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes.

Natividad Cuende, Concha Herrera, Armand Keating.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23449595      PMCID: PMC3659925          DOI: 10.3324/haematol.2013.086231

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation.

Authors:  J R Crosby; W E Kaminski; G Schatteman; P J Martin; E W Raines; R A Seifert; D F Bowen-Pope
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

2.  Adult stem cell therapies walk the line.

Authors:  Laura DeFrancesco
Journal:  Nat Biotechnol       Date:  2012-08       Impact factor: 54.908

3.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Authors:  M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

Review 4.  The bone marrow-cardiac axis: role of endothelial progenitor cells in heart failure.

Authors:  Simon Maltais; Louis P Perrault; Hung Q Ly
Journal:  Eur J Cardiothorac Surg       Date:  2011-03       Impact factor: 4.191

5.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.

Authors:  T Takahashi; C Kalka; H Masuda; D Chen; M Silver; M Kearney; M Magner; J M Isner; T Asahara
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

Review 6.  Concise review: bone marrow mononuclear cells for the treatment of ischemic syndromes: medicinal product or cell transplantation?

Authors:  Natividad Cuende; Laura Rico; Concha Herrera
Journal:  Stem Cells Transl Med       Date:  2012-05-03       Impact factor: 6.940

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.